Top

Published in:

01-02-2010

Combined percutaneous–endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome

Authors: C. P. Neal, S. C. Thomasset, D. Bools, C. D. Sutton, G. Garcea, C. D. Mann, Y. Rees, C. Newland, R. J. Robinson, A. R. Dennison, D. P. Berry

Published in: Surgical Endoscopy | Issue 2/2010

Abstract

Background

In patients in whom attempted endoscopic stenting of malignant biliary obstruction fails, combined percutaneous–endoscopic stenting and percutaneous stenting using expandable metallic endoprostheses offer alternative approaches to biliary drainage. Despite the popularity of the percutaneous route, there is no available evidence to support its superiority over combined stenting in this patient group. The objective of this study was to present the short- and long-term results of a large series of combined percutaneous–endoscopic stenting procedures and identify factors associated with adverse outcome.

Methods

Data were retrospectively collected on patients undergoing combined percutaneous–endoscopic biliary stenting for malignant biliary obstruction between January 2002 and December 2006. Short- and long-term outcomes were recorded, and pre-procedure variables correlated with adverse outcome.

Results

Combined biliary stenting was technically successful in 102 (96.2%) of 106 patients. Procedure-associated mortality rate was 0%. In-hospital morbidity and mortality rates were 24.5% and 16.7%, respectively, with the majority of deaths resulting from biliary sepsis. Median survival was 100 days, with a 13.7% stent occlusion rate. On multivariable analysis, baseline American Society of Anaesthesiologists (ASA) grade, decreasing serum albumin and increasing leucocyte count were independently associated with in-hospital mortality following combined stenting.

Conclusion

Combined biliary stenting is associated with short- and long-term outcomes equal to those reported in recent series of percutaneous transhepatic stenting. Randomised control trials, including cost-effectiveness analyses, are required to further compare these techniques. Outcomes following combined stenting may be further improved by early recognition and treatment of sepsis and scrupulous management of co-morbid disease.

Moss AC, Morris E, Leyden J, MacMathuna P (2007) Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 33:213–221CrossRefPubMed

Moss AC, Morris E, Mac Mathuna P (2006) Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev CD004200

Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW et al (1987) Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 2:57–62CrossRefPubMed

Alfke H, Alfke B, Froelich JJ, Klose KJ, Wagner HJ (2003) Treatment of malignant biliary occlusion by means of transhepatic percutaneous biliary drainage with insertion of metal stents—results of an 8-year follow-up and analysis of the prognostic parameters. Rofo 175:1125–1129PubMed

Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73CrossRefPubMed

Inal M, Akgul E, Aksungur E, Demiryurek H, Yagmur O (2003) Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 44:139–146CrossRefPubMed

Indar AA, Lobo DN, Gilliam AD, Gregson R, Davidson I, Whittaker S et al (2003) Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 15:915–919CrossRefPubMed

Lammer J, Hausegger KA, Fluckiger F, Winkelbauer FW, Wildling R, Klein GE et al (1996) Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 201:167–172PubMed

Lee BH, Choe DH, Lee JH, Kim KH, Chin SY (1997) Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol 168:741–745PubMed

10.

Rieber A, Brambs HJ (1997) Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol 20:43–49CrossRefPubMed

11.

Tesdal IK, Adamus R, Poeckler C, Koepke J, Jaschke W, Georgi M (1997) Therapy for biliary stenoses and occlusions with use of three different metallic stents: single-center experience. J Vasc Interv Radiol 8:869–879CrossRefPubMed

12.

Tsang TK, Crampton AR, Bernstein JR, Ramos SR, Wieland JM (1987) Percutaneous-endoscopic biliary stent placement. A preliminary report. Ann Intern Med 106:389–392PubMed

13.

Banerjee B, Harshfield DL, Thomas GA, Waits WJ, Teplick SK (1994) A modified combined percutaneous and endoscopic procedure for biliary stent placement. J Interven Radiol 9:153–159

14.

Dowsett JF, Vaira D, Hatfield AR, Cairns SR, Polydorou A, Frost R et al (1989) Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology 96:1180–1186PubMed

15.

Hunt JB, Sayer JM, Jacyna M, Crofton M, Summerfield JA (1993) Combined percutaneous transhepatic and endoscopic placement of biliary stents. Surg Oncol 2:293–298CrossRefPubMed

16.

Verstandig AG, Goldin E, Sasson T, Weinberger G, Wengrower D, Fich A et al (1993) Combined transhepatic and endoscopic procedures in the biliary system. Postgrad Med J 69:384–388CrossRefPubMed

17.

Wayman J, Mansfield JC, Matthewson K, Richardson DL, Griffin SM (2003) Combined percutaneous and endoscopic procedures for bile duct obstruction: simultaneous and delayed techniques compared. Hepatogastroenterology 50:915–918PubMed

18.

Blamey SL, Fearon KC, Gilmour WH, Osborne DH, Carter DC (1983) Prediction of risk in biliary surgery. Br J Surg 70:535–538CrossRefPubMed

19.

Bonnel D, Ferrucci JT Jr, Mueller PR, Lacaine F, Peterson HF (1984) Surgical and radiological decompression in malignant biliary obstruction: a retrospective study using multivariate risk factor analysis. Radiology 152:347–351PubMed

20.

Han XC, Li JL, Han G (2003) Surgical mortality in patients with malignant obstructive jaundice: a multivariate discriminant analysis. Hepatobiliary Pancreat Dis Int 2:435–440PubMed

21.

Pellegrini CA, Allegra P, Bongard FS, Way LW (1987) Risk of biliary surgery in patients with hyperbilirubinemia. Am J Surg 154:111–117CrossRefPubMed

22.

Su CH, P’Eng FK, Lui WY (1992) Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 16:536–540CrossRefPubMed

23.

Prat F, Chapat O, Ducot B, Ponchon T, Fritsch J, Choury AD et al (1998) Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 42:76–80PubMedCrossRef

24.

Rai R, Dick R, Doctor N, Dafnios N, Morris R, Davidson BR (2000) Predicting early mortality following percutaneous stent insertion for malignant biliary obstruction: a multivariate risk factor analysis. Eur J Gastroenterol Hepatol 12:1095–1100CrossRefPubMed

25.

Martin DF (1994) Combined percutaneous and endoscopic procedures for bile duct obstruction. Gut 35:1011–1012CrossRefPubMed

26.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655CrossRefPubMed

27.

Schmassmann A, von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F (1996) Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 91:654–659PubMed

28.

Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM (2002) Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol 97:898–904CrossRefPubMed

29.

Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB (1999) Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc 49:466–471CrossRefPubMed

Title: Combined percutaneous–endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome
Authors: C. P. Neal
S. C. Thomasset
D. Bools
C. D. Sutton
G. Garcea
C. D. Mann
Y. Rees
C. Newland
R. J. Robinson
A. R. Dennison
D. P. Berry
Publication date: 01-02-2010
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 2/2010
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-009-0586-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Combined percutaneous–endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2010

Partial amniotic carbon dioxide insufflation (PACI) during minimally invasive fetoscopic surgery: early clinical experience in humans

Insulation failure in laparoscopic instruments

Long-term results of laparoscopic repair of incisional hernias using an intraperitoneal composite mesh

News and Notices

Is a bougie required for the performance of the fundal wrap during laparoscopic Nissen fundoplication?

Human natural orifice translumenal endoscopic surgery: on the way to two different philosophies?